Which are the causes of Recurrent Respiratory Papillomatosis?

Recurrent Respiratory Papillomatosis (RRP) is primarily caused by infection with the human papillomavirus (HPV), most commonly types 6 and 11, which leads to the growth of noncancerous tumors in the respiratory tract. While the virus is the essential trigger, the exact mechanism that causes some individuals to develop persistent, recurring growths while others clear the infection remains a subject of ongoing medical research.

What is the primary cause of Recurrent Respiratory Papillomatosis?

The fundamental cause of Recurrent Respiratory Papillomatosis is the infection of the laryngeal epithelium by HPV types 6 and 11. These viruses are widespread, but in the vast majority of the population, the immune system successfully clears the virus. In individuals with Recurrent Respiratory Papillomatosis, the virus establishes a persistent infection, leading to the proliferation of squamous cell papillomas. These growths typically occur at sites where respiratory mucosa transitions from one cell type to another, making the vocal cords a common location.

Is Recurrent Respiratory Papillomatosis hereditary?

Recurrent Respiratory Papillomatosis is not considered a hereditary genetic disorder; it is an infectious disease. There are no known specific gene mutations that cause the condition. However, researchers are investigating why certain immune system variations—specifically those involving human leukocyte antigen (HLA) types—might make some people more susceptible to persistent HPV infection. This suggests that while it isn't "inherited" in the traditional sense, subtle differences in how our immune system recognizes HPV may influence the clinical course of Recurrent Respiratory Papillomatosis.

What are the known risk factors for Recurrent Respiratory Papillomatosis?

While the virus is the cause, researchers distinguish between causes and risk factors. Risk factors for Recurrent Respiratory Papillomatosis include:

• Age of onset: The disease is often categorized into juvenile-onset (diagnosed before age 12) and adult-onset.


• Mode of delivery: For juvenile-onset cases, exposure to HPV during passage through the birth canal of an infected mother is a significant risk factor.


• Immune function: Individuals with compromised or uniquely reactive immune systems may struggle to suppress viral replication, leading to the "recurrent" nature of Recurrent Respiratory Papillomatosis.

Current research into the etiology of Recurrent Respiratory Papillomatosis

Current research is focused on why the virus remains latent or active in the respiratory tract. Scientists are exploring the role of the local microenvironment, such as changes in the microbiome or local inflammation, which may create a favorable "niche" for the virus to thrive. With 156 people in the DiseaseMaps.org community sharing their experiences, these real-world data points are becoming increasingly valuable to clinical researchers trying to understand the disease's unpredictable progression.

Next steps

• Consult an otolaryngologist (ENT) specializing in airway disorders for surveillance and management.


• Join the 156-member community at DiseaseMaps.org to connect with others and share experiences.


• Discuss potential clinical trials or new adjuvant therapies with your specialist if you face frequent recurrences.

Medical disclaimer: This information is for educational purposes and should not replace professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Recurrent Respiratory Papillomatosis.


• Orphanet: Recurrent respiratory papillomatosis (ORPHA:688).


• PubMed/NCBI: "Pathophysiology and management of recurrent respiratory papillomatosis."


• Recurrent Respiratory Papillomatosis Foundation (RRPF).